UAE Weight Loss and Obesity Management Market Research Report: Forecast (2026-2032)

UAE Weight Loss and Obesity Management Market Report Key Takeaways:

• The UAE Weight Loss and Obesity Management Market size was valued at around USD 48.12 million in 2025 and is projected to reach USD 112 million by 2032. The estimated CAGR from 2026 to 2032 is around 12.83%, indicating strong growth.
• By product type, the dietary supplements & nutraceuticals segment represented 48% of the UAE Weight Loss and Obesity Management Market size in 2025.
• By product form, the capsules hold around 34% share of the UAE Weight Loss and Obesity Management Market in 2025.
• By region, Dubai leads the UAE Weight Loss and Obesity Management Market with a market share of around 54% in 2025.
• By service, the online weight loss programs segment is projected to grow with a CAGR of around 18% during 2026-32.
• The leading weight loss and obesity management companies in the UAE are Eli Lilly and Company, Novo Nordisk A/S, Dardoc Health Technologies Limited, VIVUS LLC, Herbalife Ltd., Alma Health, Nestlé Health Science S.A., Atkins Nutritionals, Inc., Glanbia plc, Dr. Nutrition, 21st Century Healthcare Inc., Clinical Products LLC, Abbott Laboratories SA, and others.

Market Insights & Analysis: UAE Weight Loss and Obesity Management Market (2026-2032):

The UAE Weight Loss and Obesity Management Market size was valued at around USD 48.12 million in 2025 and is projected to reach USD 112 million by 2032. Along with this, the market is estimated to grow at a CAGR of around 12.83% during the forecast period, i.e., 2026-32.

The UAE Weight Loss and Obesity Management Market is experiencing rapid growth, driven by pronounced regional disparities in obesity prevalence, accelerating adoption of digital health platforms, and long-term demographic projections that point to a structurally rising patient base.

Data from the Ministry of Health and Prevention (MoHAP) highlights the scale and geographic spread of obesity across the UAE, revealing a structurally embedded public health challenge. For instance, Abu Dhabi records an adult obesity rate of 35.9%, markedly higher than the national average of 27.8%, pointing to concentrated risk shaped by local lifestyle and dietary dynamics.

Similarly, Dubai, despite its strong wellness culture, still reports 22.2% adult obesity, demonstrating that urban affluence and health awareness do not insulate populations from metabolic risk. Sharjah follows closely at 24.4%, while the burden becomes even more pronounced across smaller emirates, where obesity exceeds 38% in Ras Al Khaimah and reaches 39.1% in Ajman and Fujairah. These disparities show that obesity transcends income, age, and geography, constituting a nationwide structural burden that demands scalable, region-sensitive weight-management solutions across the UAE.

Parallel to this epidemiological pressure, the integration of digital health tools is reshaping how weight-related conditions are monitored and managed. By service, the online weight loss programs segment is expanding at a CAGR of 18%, reflecting strong consumer preference for app-based coaching, virtual consultations, and data-driven lifestyle interventions. For example, in early 2025, Abu Dhabi’s Sahatna app surpassed 300,000 downloads, enabling access to approximately 870,000 lab results and 440,000 prescription records. Such platforms embed health tracking into daily routines, supporting continuous monitoring of lifestyle conditions and reinforcing a shift toward proactive, data-driven obesity management.

Long-term projections further reinforce the market’s growth trajectory. For example, Lancet-derived estimates indicate that overweight and obesity prevalence among UAE adults aged 25+ could rise from about 84% to nearly 94% among males and 95% among females by 2050. Among youth aged 15–24, prevalence is projected to climb from 62% to roughly 81% over the same period. These forecasts point to a rapidly expanding population requiring structured, long-term weight-management solutions.

Furthermore, institutionally, MoHAP’s continued enhancement of national health surveys (2024–2025) and development of obesity prevention frameworks signal sustained policy focus through 2030 and beyond. This data-driven governance model supports early intervention strategies, standardized clinical pathways, and scalable preventive programs.

The convergence of high regional obesity rates, technology-enabled care models, and stark long-term prevalence projections positions the UAE obesity management market for structural growth. These forces will continue to expand demand for clinical therapies, digital platforms, and integrated weight-management solutions across the country.

UAE Weight Loss and Obesity Management Market Recent Developments:

• November 2025: Novo Nordisk UAE unveiled the “You Are The New Champion” initiative during the Dubai Fitness Challenge 2025, reinforcing a science-led approach to obesity care. The campaign promotes awareness, early screening, and long-term behavioral change, guiding individuals toward clinically validated weight-management pathways. It supports the UAE’s National Nutrition Strategy by reframing obesity as a chronic condition requiring structured, evidence-based intervention.
• March 2025: VIVUS has launched QSYMIA® (phentermine/topiramate extended-release), marking its first Middle Eastern market entry for this prescription obesity treatment proven to support weight reduction when combined with diet and exercise. The approval expands therapeutic options for adults and adolescents aged 12+ struggling with obesity, aligning with UAE public health efforts to address rising obesity prevalence.

UAE Weight Loss and Obesity Management Market Scope:

UAE Weight Loss and Obesity Management Market Drivers:

Increasing Rate of Obesity Augments Market Growth

The United Arab Emirates is experiencing a deepening public health challenge as obesity rates continue to rise across age groups and demographics, directly accelerating demand for structured weight-management solutions.

For instance, data released by the Ministry of Health and Prevention (MoHAP) shows that adult obesity prevalence reached 27.8% in early 2024, with a marked gender gap 30.6% among women versus 25.1% among men. The burden is even heavier among Emirati nationals, where obesity affects 36.9% of the population, compared with 26.3% among residents, reflecting both cultural and lifestyle-driven risk patterns.

Unhealthy consumption patterns remain deeply embedded in daily routines. For instance, the National Health and Nutrition Survey indicates that 27.3% of adults exceed recommended sugar intake, while 27.4% consume sugar-sweetened beverages every day. Such habits accelerate weight gain, elevate insulin resistance, and increase lifetime exposure to obesity-related metabolic diseases.

The challenge begins early. For instance, nearly 40% of children in the UAE are overweight or obese, reflecting early exposure to sedentary lifestyles and calorie-dense diets. This trajectory increases lifetime health risks and establishes a growing cohort that will require sustained clinical and preventive weight-management support.

The scale and persistence of obesity across adults and children are reshaping healthcare priorities in the UAE. This epidemiological pressure will continue to fuel sustained growth in demand for medical, digital, and preventive obesity management solutions nationwide.

UAE Weight Loss and Obesity Management Market Trends:

Integration of Digital Health Tools Changing Market Dynamics

The UAE’s rapid digital transformation in healthcare is reshaping how obesity and chronic conditions are monitored, prevented, and treated. During 2024, the Ministry of Health and Prevention (MoHAP) accelerated nationwide adoption of advanced digital platforms, AI-driven systems, and real-time health data infrastructure to modernize care delivery and strengthen preventive health frameworks.

A defining milestone is MoHAP’s “Biosigns” project, introduced in 2025. This AI-powered solution transforms smartphone cameras into medical tools capable of measuring vital signs and linking them with unified electronic medical records. By enabling remote and continuous health monitoring, Biosigns supports early detection of physiological changes associated with lifestyle diseases such as obesity, facilitating timely clinical intervention and long-term tracking.

At the emirate level, Abu Dhabi’s Intelligent Health System and the Sahatna platform have expanded mobile access to healthcare services for over 800,000 residents. These platforms provide real-time access to personal medical records, teleconsultations, wellness dashboards, and behavior-guidance features. Such tools shift obesity management from episodic, clinic-based treatment toward continuous, data-driven lifestyle oversight.

Overall, Government-led digital health integration is redefining obesity care in the UAE by enabling continuous monitoring, early intervention, and personalized treatment. This structural shift is accelerating demand for app-based, AI-enabled weight-management solutions, positioning digital platforms as a core growth engine for the market.

UAE Weight Loss and Obesity Management Market Challenges:

High Treatment Costs Impeding Market Expansion

Rising treatment costs remain a structural constraint on the UAE’s weight loss and obesity management market, limiting access to care despite growing clinical need. Government-linked assessments project direct medical spending on overweight and obesity to rise from about USD 1.4 billion to USD 1.9 billion by 2035, underscoring the growing financial burden of long-term therapies, diagnostics, and specialist care.

For individuals, these costs often translate into high out-of-pocket spending, particularly as many insurance policies in the UAE continue to restrict coverage for anti-obesity medications and structured weight-management programs.

As advanced therapies and personalized care models become more prominent, affordability emerges as a critical barrier, especially for middle-income populations and long-term users requiring sustained intervention.

From a system perspective, growing fiscal pressure on healthcare budgets may constrain the pace at which obesity services can be scaled across public and private providers. Without broader reimbursement frameworks or cost-containment mechanisms, access remains uneven.

Overall, escalating treatment costs restrict adoption and delay intervention, narrowing the addressable patient base. Unless affordability improves, financial barriers will continue to hamper market expansion and limit equitable access to effective obesity care in the UAE.

UAE Weight Loss and Obesity Management Market (2026-32) Segmentation Analysis:

The UAE Weight Loss and Obesity Management Market Report and Forecast 2026-2032 offers a detailed analysis of the market based on the following segments:

Based on Product Type:

• Dietary Supplements & Nutraceuticals
  • Meal Replacements
  • Beverages
  • Supplements
• Prescription & OTC Therapeutics
  • RX anti-obesity drugs
  • OTC weight-loss products
  • Conjugated therapies
• Others

The dietary supplements & nutraceuticals segment now holds the top spot in the UAE Weight Loss and Obesity Management Market, with a market share of around 48%. Market dominance is driven by strong consumer inclination toward preventive, non-prescription solutions.

This dominance is underpinned by the country’s wellness-oriented culture, where weight management is closely associated with fitness, appearance, and long-term health rather than clinical intervention alone.

Meal replacements, functional beverages, and nutritional supplements are widely available through pharmacies, supermarkets, e-commerce platforms, and fitness centers, ensuring broad accessibility across income groups.

Meal replacement shakes and protein beverages have become integral to gym routines and digital fitness programs, reinforcing habitual consumption. Within this segment, slimming teas are emerging as a high-growth subcategory, expanding at a CAGR of approximately 37%, driven by demand for herbal, detox-oriented, and easy-to-consume formats.

Additionally, the UAE’s large expatriate population and younger demographics exhibit strong familiarity with global nutraceutical brands and a growing preference for clean-label, plant-based formulations.

Compared with prescription therapies, nutraceuticals offer lower entry costs, minimal regulatory friction, and faster product innovation cycles. Their ease of adoption, combined with strong retail visibility and lifestyle alignment, positions this segment as the primary gateway into weight management for a broad consumer base.

Based on Product Form:

• Tablets
• Capsules
• Liquids
• Soft Gels
• Powders
• Premixes
• Gummies & Jellies
• Others

The capsules category leads the UAE Weight Loss and Obesity Management Industry, accounting for 34% of market share, reflecting their strong acceptance across both clinical and consumer-led weight management programs.

Their leadership is driven by precise dosing, extended shelf life, and superior formulation stability, which make them ideal for housing complex active ingredients such as GLP-1 adjuncts, botanical extracts, probiotics, and metabolic enhancers. Unlike liquids or powders, capsules eliminate taste barriers, improving patient compliance over long treatment cycles. They also enable controlled-release mechanisms, allowing gradual absorption that supports sustained appetite regulation and metabolic balance.

From a manufacturing standpoint, capsules offer cost-efficient large-scale production, simplified packaging, and easier regulatory standardization compared to gummies or premixes. In the UAE, where physician-prescribed and pharmacy-dispensed solutions play a central role, capsules align well with medical prescribing habits and patient trust in pharmaceutical formats. Their portability further enhances adoption among working professionals and frequent travelers.

Together, these advantages position capsules as the preferred delivery form for both therapeutic and supplemental weight-management solutions, sustaining their leadership across retail and clinical channels.

UAE Weight Loss and Obesity Management Market (2026-32): Regional Projection

The UAE Weight Loss and Obesity Management Market is dominated by the Dubai region, which holds a commanding 54% share, underpinned by its highly developed healthcare ecosystem, elevated consumer spending power, and role as a regional medical hub.

The emirate hosts the country’s densest concentration of private hospitals, specialty clinics, and wellness centers offering comprehensive obesity care, including advanced pharmacotherapies, bariatric procedures, and digitally enabled weight-management programs.

Dubai’s healthcare environment enables rapid adoption of innovative therapies, supported by a mature insurance landscape and a strong private-sector presence. A large expatriate population with employer-sponsored coverage, coupled with affluent residents prioritizing preventive healthcare, sustains higher per-capita expenditure on lifestyle and metabolic health services.

Strategic government initiatives, including Dubai Health Strategy 2030 and system-wide digital integration through NABIDH, have streamlined patient pathways, enhanced data continuity, and improved access to specialist care. Additionally, Dubai’s position as a medical tourism destination attracts patients from across the GCC, South Asia, and Africa, extending demand beyond the resident population.

Overall, these structural advantages position Dubai as the UAE’s primary obesity-care hub, sustaining market leadership and driving disproportionate revenue generation through innovation, accessibility, and regional patient inflows.

Gain a Competitive Edge with Our UAE Weight Loss and Obesity Management Market Report:

• UAE Weight Loss and Obesity Management Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
• This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
• UAE Weight Loss and Obesity Management Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.